Patents by Inventor Herbert G. Wheeler

Herbert G. Wheeler has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • INHIBITION OF MAMMALIAN TARGET OF RAPAMYCIN
    Publication number: 20220023230
    Abstract: Disclosed are microcapsules that include an inhibitor of the mammalian target of rapamycin (mTOR) within the microcapsules, and pharmaceutical compositions and kits that include the microcapsules. Also disclosed are methods for treating or preventing an age-related disease, condition, or disorder in a subject that involve administering to a subject a pharmaceutically effective amount of microcapsules that includes an inhibitor of mTOR within the microcapsules.
    Type: Application
    Filed: July 28, 2021
    Publication date: January 27, 2022
    Inventors: Zelton Dave Sharp, John R. Strong, Veronica Galvan, Salvatore Oddo, Herbert G. Wheeler
  • Inhibition of mammalian target of rapamycin
    Patent number: 11110067
    Abstract: Disclosed are microcapsules that include an inhibitor of the mammalian target of rapamycin (mTOR) within the microcapsules, and pharmaceutical compositions and kits that include the microcapsules. Also disclosed are methods for treating or preventing an age-related disease, condition, or disorder in a subject that involve administering to a subject a pharmaceutically effective amount of microcapsules that includes an inhibitor of mTOR within the microcapsules.
    Type: Grant
    Filed: August 27, 2019
    Date of Patent: September 7, 2021
    Assignees: The Board of Regents of the University of Texas System, Southwest Research Institute
    Inventors: Zelton Dave Sharp, John R. Strong, Veronica Galvan, Salvatore Oddo, Herbert G. Wheeler
  • INHIBITION OF MAMMALIAN TARGET OF RAPAMYCIN
    Publication number: 20200054576
    Abstract: Disclosed are microcapsules that include an inhibitor of the mammalian target of rapamycin (mTOR) within the microcapsules, and pharmaceutical compositions and kits that include the microcapsules. Also disclosed are methods for treating or preventing an age-related disease, condition, or disorder in a subject that involve administering to a subject a pharmaceutically effective amount of microcapsules that includes an inhibitor of mTOR within the microcapsules.
    Type: Application
    Filed: August 27, 2019
    Publication date: February 20, 2020
    Inventors: Zelton Dave Sharp, John R. Strong, Veronica Galvan, Salvatore Oddo, Herbert G. Wheeler
  • INHIBITION OF MAMMALIAN TARGET OF RAPAMYCIN
    Publication number: 20120064143
    Abstract: Disclosed are microcapsules that include an inhibitor of the mammalian target of rapamycin (mTOR) within the microcapsules, and pharmaceutical compositions and kits that include the microcapsules. Also disclosed are methods for treating or preventing an age-related disease, condition, or disorder in a subject that involve administering to a subject a pharmaceutically effective amount of microcapsules that includes an inhibitor of mTOR within the microcapsules.
    Type: Application
    Filed: November 11, 2009
    Publication date: March 15, 2012
    Applicant: The Board of Regents of the University of Texas System
    Inventors: Zelton Dave Sharp, John R. Strong, Veronica Galvan, Salvatore Oddo, Herbert G. Wheeler